Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel C Mok

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
The American Journal of Pathology|August 31, 2010
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomasKwong-Kwok Wong, Yvonne T M Tsang, Michael T Deavers, et al.
International Journal of Molecular Sciences|March 19, 2013
PAX2 Expression in Ovarian CancerHuijuan Song, Suet-Yan Kwan, Daisy I Izaguirre, et al.
Journal of the National Cancer Institute|June 4, 2018
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian CancerTsz-Lun Yeung, Jianting Sheng, Cecilia S Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancerJohn O Schorge, Richard D Drake, Hang Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancerJae-Hoon Kim, Dorothee Herlyn, Kwong-kwok Wong, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancerDong Choon Park, Seung Geun Yeo, Mark R Wilson, et al.
Cancer Research|November 5, 2002
Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genesVéronique Bourdon, Félix Naef, Pulivarthi H Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometryBin Ye, Daniel W Cramer, Steven J Skates, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2019
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian CancerMatthew Schwede, Levi Waldron, Samuel C Mok, et al.
Cancers|November 25, 2018
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer ProgressionTsz-Lun Yeung, Ching Chou Tsai, Cecilia S Leung, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
The American Journal of Pathology|August 31, 2010
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomasKwong-Kwok Wong, Yvonne T M Tsang, Michael T Deavers, et al.
International Journal of Molecular Sciences|March 19, 2013
PAX2 Expression in Ovarian CancerHuijuan Song, Suet-Yan Kwan, Daisy I Izaguirre, et al.
Journal of the National Cancer Institute|June 4, 2018
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian CancerTsz-Lun Yeung, Jianting Sheng, Cecilia S Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancerJohn O Schorge, Richard D Drake, Hang Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancerJae-Hoon Kim, Dorothee Herlyn, Kwong-kwok Wong, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancerDong Choon Park, Seung Geun Yeo, Mark R Wilson, et al.
Cancer Research|November 5, 2002
Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genesVéronique Bourdon, Félix Naef, Pulivarthi H Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometryBin Ye, Daniel W Cramer, Steven J Skates, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2019
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian CancerMatthew Schwede, Levi Waldron, Samuel C Mok, et al.
Cancers|November 25, 2018
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer ProgressionTsz-Lun Yeung, Ching Chou Tsai, Cecilia S Leung, et al.
Pageof 15